Drug Legislation

States that approved caps to limit out-of-pocket costs for insulin did not have increased uptake in insulin use among people with diabetes and commercial insurance, according to findings published in Health Affairs.

A bill proposed in the U.S Senate would limit out-of-pocket insulin costs for Americans with diabetes who have commercial health insurance, according to a press release.

A bill to cap the cost of insulin prices at $35 per month for Americans with diabetes was approved by the U.S. House of Representatives this afternoon.

Two professional endocrine societies are formally opposing legislative efforts to block transgender people from accessing gender-affirming medical and surgical care, after dozens of state bills threatened to criminalize such therapies.

The legalization of marijuana, especially for recreational use, was associated with significant reductions in opioid-related mortality, according to study results published in Economic Inquiry.